The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Transforming growth factor β and tumor necrosis factor α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
Abstract
Transforming growth factor β (TGF-β) as well as tumor necrosis factor α (TNF-α) gene expression are up-regulated in chronically inflamed liver. These cytokines were investigated for their influence on apoptosis and proliferation of activated hepatic stellate cells (HSCs). Spontaneous apoptosis in activated HSC was significantly down-regulated by 53% ± 8% (P < .01) under the influence of TGF-β and by 28% ± 2% (P < .05) under the influence of TNF-α. TGF-β and TNF-α significantly reduced expression of CD95L in activated HSCs, whereas CD95 expression remained unchanged. Furthermore, HSC apoptosis induced by CD95-agonistic antibodies was reduced from 96% ± 2% to 51 ± 7% (P < .01) by TGF-β, and from 96% ± 2% to 58 ± 2% (P < .01) by TNF-α, suggesting that intracellular antiapoptotic mechanisms may also be activated by both cytokines. During activation, HSC cultures showed a reduced portion of cells in the G 0/G 1 phase and a strong increment of G 2-phase cells. This increment was significantly inhibited (G 1 arrest) by administration of TGF-β and/or TNF-α to activated cells. In liver sections of chronically damaged rat liver (CCl 4 model), using desmin and CD95L as markers for activated HSC, most of these cells did not show apoptotic signs (TUNEL-negative). Taken together, these findings indicate that TGF-β and/or TNF-α both inhibit proliferation and also apoptosis in activated HSC in vitro. Both processes seem to be linked to each other, and their inhibition could represent the mechanism responsible for prolonged survival of activated HSC in chronic liver damage in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Cited by
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
Weber, L. W. D., Boll, M., & Stampfl, A. (2003) · Critical Reviews in Toxicology · doi:10.1080/713611034 · Cited by 1,777
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
“Also the functionality of TGF-β on apoptosis is potentially dependent on the culture conditions [88, 89].”
BackgroundMurphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111490200 · Cited by 432
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · Apoptosis · doi:10.1007/s10495-005-1055-4 · Cited by 419
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Hazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310284200 · Cited by 320
Reif, S., Lang, A., Lindquist, J. N., Yata, Y., Gäbele, E., Scanga, A., Brenner, D. A., & Rippe, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212927200 · Cited by 298
Hepatic stellate cells and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04584.x · Cited by 278
Hepatic stellate cells: a target for the treatment of liver fibrosis
Wu, J., & Zern, M. A. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070045 · Cited by 273
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells
Parekkadan, B., van Poll, D., Megeed, Z., Kobayashi, N., Tilles, A. W., Berthiaume, F., & Yarmush, M. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.150 · Cited by 252
Nakamura, T., Torimura, T., Sakamoto, M., Hashimoto, O., Taniguchi, E., Inoue, K., Sakata, R., Kumashiro, R., Murohara, T., Ueno, T., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.110 · Cited by 156
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
Di Sario, A., Bendia, E., Svegliati Baroni, G., Ridolfi, F., Casini, A., Ceni, E., Saccomanno, S., Marzioni, M., Trozzi, L., Sterpetti, P., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00245-3 · Cited by 138
Role of iron in hepatic fibrosis: One piece in the puzzle
Philippe, M. A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4746 · Cited by 95
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Wang, J., Bian, C., Liao, L., Zhu, Y., Li, J., Zeng, L., & Zhao, R. C. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00564.x · Cited by 54
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
Pinheiro, D., Dias, I., Ribeiro Silva, K., Stumbo, A. C., Thole, A., Cortez, E., de Carvalho, L., Weiskirchen, R., & Carvalho, S. (2019) · Cells · doi:10.3390/cells8111339 · Cited by 46
Karimizadeh, E., Gharibdoost, F., Motamed, N., Jafarinejad-Farsangi, S., Jamshidi, A., & Mahmoudi, M. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2408-0 · Cited by 20
Koda, M., Bauer, M., Krebs, A., Hahn, E. G., Schuppan, D., & Murawaki, Y. (2006) · Comparative Hepatology · doi:10.1186/1476-5926-5-5 · Cited by 17
Metadata
- Authors
- Saile, B., Matthes, N., Knittel, T., & Ramadori, G.
- Venue
- Hepatology
- Published
- 1999-07
- Volume
- 30
- Issue
- 1
- Pages
- 196-202
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2082279739
- Cited by
- 158
- References
- 1
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.